By Martha Rosenberg | CounterPunch | May 16, 2018 How high are Pharma’s prices? Novartis wants $475,000 a patient for its new cancer therapy. Hep C drugs cost $95,000 for a course of treatment. The immune drug, Actimmune, costs $52,321.80 a month. The parasite drug Daraprim costs $45,000 a month. And the gallstone drug Chenodal costs $42,570 a […]
Source